查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386264

阑尾炎诊断与治疗市场报告：2030 年趋势、预测与竞争分析

Appendicitis Diagnostics and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

阑尾炎诊断和治疗的趋势和预测

2030年，全球阑尾炎诊断和治疗市场预计将达到140亿美元，2024年至2030年年复合成长率为7.1%。该市场的主要驱动因素是阑尾炎和儿童阑尾炎盛行率的不断上升、人们对阑尾炎的认识不断增强以及全球整体医疗保健支出的增加。全球阑尾炎诊断和治疗市场的未来前景广阔，医院、诊所和诊断影像中心市场充满商机。

阑尾炎诊断和治疗市场洞察

急性阑尾炎的特征是阑尾发炎在数小时至数天内快速发作，Lucintel 预测在预测期内将出现高成长。

医院和诊所可能仍然是市场中最大的部分。

由于阑尾炎的高发病率以及人们对该疾病的认识不断提高，北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球阑尾炎诊疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球阑尾炎诊断和治疗市场趋势（2018-2023）和预测（2024-2030）
  • 按类型分類的全球阑尾炎诊断和治疗市场
    • 急性
    • 慢性的
  • 按诊断治疗分類的全球阑尾炎诊断与治疗市场
    • 诊断
    • 治疗
  • 按最终用途分類的全球阑尾炎诊断和治疗市场
    • 医院
    • 诊所
    • 影像诊断中心

第4章2018-2030年分地区市场趋势及预测分析

  • 全球阑尾炎诊断和治疗市场（按地区）
  • 北美阑尾炎诊断与治疗市场
  • 欧洲阑尾炎诊断与治疗市场
  • 亚太地区阑尾炎诊断与治疗市场
  • 其他区域性阑尾炎诊疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球阑尾炎诊断和治疗市场成长机会（按类型）
    • 全球阑尾炎诊断和治疗市场诊断治疗的成长机会
    • 全球阑尾炎诊断和治疗市场成长机会（按最终用途）
    • 全球阑尾炎诊断和治疗市场按地区成长机会
  • 全球阑尾炎诊断和治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球阑尾炎诊断和治疗市场的能力
    • 全球阑尾炎诊断和治疗市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Johnshon & Johnshon
  • Pfizer
  • Lupin
  • Siemens
  • Medtronic
  • Cook
  • Teva Pharmaceutical industries
简介目录

Appendicitis Diagnostics and Treatment Trends and Forecast

The future of the global appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets. The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

A more than 150-page report is developed to help in your business decisions.

Appendicitis Diagnostics and Treatment by Segment

The study includes a forecast for the global appendicitis diagnostics and treatment by type, diagnosis treatment, end use, and region.

Appendicitis Diagnostics and Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Acute
  • Chronic

Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnosis
  • Treatment

Appendicitis Diagnostics and Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Diagnostic Imaging Centers

Appendicitis Diagnostics and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Appendicitis Diagnostics and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies appendicitis diagnostics and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the appendicitis diagnostics and treatment companies profiled in this report include-

  • Johnshon & Johnshon
  • Pfizer
  • Lupin
  • Siemens
  • Medtronic
  • Cook
  • Teva Pharmaceutical Industries

Appendicitis Diagnostics and Treatment Market Insights

Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Within this market, hospitals & clinics will remain the largest segment.

North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Features of the Global Appendicitis Diagnostics and Treatment Market

Market Size Estimates: Appendicitis diagnostics and treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Appendicitis diagnostics and treatment market size by type, diagnosis treatment, end use, and region in terms of value ($B).

Regional Analysis: Appendicitis diagnostics and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis treatments, end uses, and regions for the appendicitis diagnostics and treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the appendicitis diagnostics and treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the appendicitis diagnostics and treatment market size?

Answer: The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030.

Q.2 What is the growth forecast for appendicitis diagnostics and treatment market?

Answer: The global appendicitis diagnostics and treatment market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the appendicitis diagnostics and treatment market?

Answer: The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

Q4. What are the major segments for appendicitis diagnostics and treatment market?

Answer: The future of the appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets.

Q5. Who are the key appendicitis diagnostics and treatment market companies?

Answer: Some of the key appendicitis diagnostics and treatment companies are as follows:

  • Johnshon & Johnshon
  • Pfizer
  • Lupin
  • Siemens
  • Medtronic
  • Cook
  • Teva Pharmaceutical Industries

Q6. Which appendicitis diagnostics and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Q7. In appendicitis diagnostics and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the appendicitis diagnostics and treatment market by type (acute and chronic), diagnosis treatment (diagnosis and treatment), end use (hospitals, clinics, and diagnostic imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Appendicitis Diagnostics and Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Appendicitis Diagnostics and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Appendicitis Diagnostics and Treatment Market by Type
    • 3.3.1: Acute
    • 3.3.2: Chronic
  • 3.4: Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
    • 3.4.1: Diagnosis
    • 3.4.2: Treatment
  • 3.5: Global Appendicitis Diagnostics and Treatment Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Diagnostic Imaging Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Appendicitis Diagnostics and Treatment Market by Region
  • 4.2: North American Appendicitis Diagnostics and Treatment Market
    • 4.2.2: North American Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
  • 4.3: European Appendicitis Diagnostics and Treatment Market
    • 4.3.1: European Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
    • 4.3.2: European Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
  • 4.4: APAC Appendicitis Diagnostics and Treatment Market
    • 4.4.1: APAC Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
    • 4.4.2: APAC Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
  • 4.5: ROW Appendicitis Diagnostics and Treatment Market
    • 4.5.1: ROW Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
    • 4.5.2: ROW Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
    • 6.1.3: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by End Use
    • 6.1.4: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Region
  • 6.2: Emerging Trends in the Global Appendicitis Diagnostics and Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Appendicitis Diagnostics and Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Appendicitis Diagnostics and Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Johnshon & Johnshon
  • 7.2: Pfizer
  • 7.3: Lupin
  • 7.4: Siemens
  • 7.5: Medtronic
  • 7.6: Cook
  • 7.7: Teva Pharmaceutical industries